Announcements
Season Greetings From CellFree Sciences
Season Greetings
From CellFree Sciences!
Our way of saying thank you.
With the year ending, we want to thank you for working together with CellFree Sciences and express our sincere wishes for the Seasons and a Happy, Healthy and Prosperous New Year!
This year had been complicated for all of us with life been very much dominated by the ongoing COVID-19 pandemic and the suffering it had broad to many people worldwide. But there is also hope in the times of the pandemic, which showed more than ever the importance of life sciences and the contribution we can make to bring the pandemic to an end. It fills us with pride that also our wheat germ cell-free expression system is used in the response to the COVID-19 pandemic to prepare viral proteins for research and the development and production of diagnostic products now available on the Japanese market. CellFree Sciences is committed to keep on supporting medical research and to work for better solutions in global health.
CellFree Sciences will start into 2022 with new service for protein-protein interaction assay with using protein array and campaign for custom synthesis service.
We all at CellFree Sciences are looking forward to being at your service again in 2022 supporting your important projects with our reagents and services. Please contact us and let us know about your needs and requirements. It is our commitment to work for our customers and partners to make your projects successful.
With all the very best wishes for you and yours for a better New Year 2022 from all of us at CellFree Sciences!
Our wheat germ cell-free expression system was used in a study to clarify the side effects of thalidomide.
Furihata, H., Yamanaka, S., Honda, T. et al. published in Nature Communications the results from a jointed project conducted by researchers at the University of Tokyo, Nagoya Institute of Technology, and our strategic partner the Proteo-Science Center at Ehime University using structural biology for determining the mechanisms behind side effects of immunomodulatory drugs like Thalidomide and its metabolite 5-hydroxythalidomide.
Thalidomide is used as an effective anti-cancer drug for treatment of multiple myeloma, although it exhibits side effects that cause developmental disorders in children during pregnancy. It is hoped that the results will help in the future to design better immunomodulatory drugs that mitigate the side effects.
This publication can be freely accessed: here.
Contributed to support the development of monoclonal antibody detection of the novel coronavirus
The joint research group, which primarily studies under Dr. Akihide Ryo for Yokohama City University, has succeeded in the development of monoclonal antibodies to specifically detect novel coronavirus (SARS-CoV-2) antigens, and has utilized our company's Wheat Germ Cell-free Protein Expression System in the production of the antigen.
For further details, Please click here.
Ehime University et al. receive research grant for development of malaria vaccines
The Proteo-Science Center (PROS), Ehime University et al. research group, which is the strategic technical partner of our company, has received a research grant totaling approximately 600 million yen for research to develop transmission-blocking vaccines for malaria elimination from Global Health Innovative Technology Fund (GHIT Fund).
Up to now we have supplied wheat germ extract to support malaria research through wheat germ cell-free protein expression system and it is our hope this malaria vaccine development will be one more step of progress in the battle to malaria elimination.
Contributed to novel coronavirus antibody detection technology
Our company's Wheat Germ Cell-free Protein Expression System was used to produce the antigen necessary for antibody detection in the technology developed by Dr. Akihide Ryo of Yokohama City University that is used to detect antiviral antibodies against novel coronavirus.
NHK News Good Morning Japan Broadcasts Segment Covering Research That Makes Use of Our Products.
Our strategic technology partner, the Proteo-Science Center at Ehime University, was successfully able to synthesize almost all of the 24,000 main proteins of the human body using a wheat germ cell-free protein synthesis technology that makes use of our wheat germ extract.
A segment covering this work was broadcast nationally in Japan on the August 30 edition of NHK News Good Morning Japan.
For further details, Please click here.
We have put application notes up on our website.
CellFree Sciences have put application notes up on our website.
Please click here for more details!
Our Yokohama head office has been relocated.
Our Yokohama head office has been relocated as of July 10th, 2018.
Our telephone and fax numbers have also changed along with this relocation.
Yokohama Head Office
Yokohama Bio Industry Center, 1-6 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045 JAPAN
TEL：+81-45-345-2600 FAX：+81-45-345-2601
We look forward to your continued patronage.
CellFree Sciences Co., Ltd.
We have newly redesigned our website.
We have redesigned the entire website of CellFree Sciences.
We have a fresh new design throughout the site, so that we can better provide the information that you would like to know.
At CellFree Sciences, we will continue to use our website as a tool for enhanced communications with customers, and to pursue customer satisfaction.
Cell Free Sciences Co., Ltd.
